2813-2440

Frontiers in Transplantation

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 340 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact340 DOIs
2

Add abstracts to 27 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact27 DOIs
3

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 340 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Grand Challenges in Organ Transplantation (10.3389/frtra.2022.897679)
Abstract ORCID
84.06 47
2 Normothermic regional perfusion in paediatric donation after… (10.3389/frtra.2024.1320783)
Abstract ORCID
55.70 12
3 Promises and challenges of a decentralized CAR T-cell manufa… (10.3389/frtra.2023.1238535)
ORCID
45.15 63
4 Tregs in transplantation tolerance: role and therapeutic pot… (10.3389/frtra.2023.1217065)
ORCID
41.09 43
5 Acellular dermal matrix in reconstructive surgery: Applicati… (10.3389/frtra.2023.1133806)
ORCID
40.84 42
6 Donor-specific graft injury in solid organ transplantation:… (10.3389/frtra.2024.1427106)
Abstract ORCID
38.91 5
7 Tacrolimus—why pharmacokinetics matter in the clinic (10.3389/frtra.2023.1160752)
ORCID
37.28 30
8 Current practice and novel approaches in organ preservation (10.3389/frtra.2023.1156845)
ORCID
36.93 29
9 The transformative potential of artificial intelligence in s… (10.3389/frtra.2024.1361491)
ORCID
35.78 26
10 Ethical implications of ex vivo organ assessment and repair… (10.3389/frtra.2023.1184439)
Abstract ORCID
34.95 4
11 Immunosuppressive strategies in face and hand transplantatio… (10.3389/frtra.2024.1366243)
ORCID
34.51 23
12 Preparation of human amniotic membrane for transplantation i… (10.3389/frtra.2023.1152068)
ORCID
34.04 22
13 Supercooling: a promising technique for prolonged preservati… (10.3389/frtra.2023.1269706)
ORCID
34.04 22
14 Retrospective analysis of the incidence and outcome of late… (10.3389/frtra.2024.1332181)
ORCID
31.38 17
15 Early patient and liver allograft outcomes from donation aft… (10.3389/frtra.2023.1184620)
ORCID
30.76 16
16 The current issues of translating clinical xenokidney transp… (10.3389/frtra.2025.1559512)
Abstract ORCID
30.10 3
17 Review of machine perfusion studies in vascularized composit… (10.3389/frtra.2023.1323387)
ORCID
29.40 14
18 Immunogenicity and tolerance induction in vascularized compo… (10.3389/frtra.2024.1350546)
ORCID
28.65 13
19 The impact of socioeconomic deprivation on liver transplanta… (10.3389/frtra.2024.1352220)
ORCID
28.65 13
20 A review of cell-free DNA and epigenetics for non-invasive d… (10.3389/frtra.2024.1474920)
ORCID
28.65 13
21 Real-time assessment of kidney allografts during HOPE using… (10.3389/frtra.2023.1132673)
ORCID
27.85 12
22 Status of islet transplantation and innovations to sustainab… (10.3389/frtra.2024.1485444)
ORCID
27.85 12
23 Diagnostic and therapeutic strategies for vascular complicat… (10.3389/frtra.2023.1150331)
ORCID
26.98 11
24 Modern glucose-lowering drugs in liver transplant recipients… (10.3389/frtra.2023.1223169)
ORCID
26.98 11
25 Mass spectrometry-based proteomics for advancing solid organ… (10.3389/frtra.2023.1286881)
ORCID
26.03 10
26 Single-cell mapping of leukocyte immunoglobulin-like recepto… (10.3389/frtra.2022.952785)
ORCID
25.00 9
27 Innate immune cellular therapeutics in transplantation (10.3389/frtra.2023.1067512)
ORCID
25.00 9
28 Oxygen carriers affect kidney immunogenicity during ex-vivo… (10.3389/frtra.2023.1183908)
ORCID
25.00 9
29 Hypoxia within subcutaneously implanted macroencapsulation d… (10.3389/frtra.2023.1257029)
ORCID
25.00 9
30 2025: status of cardiac xenotransplantation including precli… (10.3389/frtra.2025.1568910)
ORCID
25.00 9
31 Immunology of simultaneous liver and kidney transplants with… (10.3389/frtra.2022.991546)
ORCID
23.86 8
32 Time for transplant care professionals to face recipients' f… (10.3389/frtra.2023.1277053)
Abstract ORCID
23.86 2
33 Immune aging: biological mechanisms, clinical symptoms, and… (10.3389/frtra.2024.1356948)
ORCID
23.86 8
34 A narrative review: predicting liver transplant graft surviv… (10.3389/frtra.2024.1378378)
ORCID
23.86 8
35 The future of islet transplantation beyond the BLA approval:… (10.3389/frtra.2025.1522409)
ORCID
23.86 8
36 Thoracic organ machine perfusion: A review of concepts with… (10.3389/frtra.2023.1060992)
ORCID
22.58 7
37 Liquid biopsy for non-invasive monitoring of patients with k… (10.3389/frtra.2023.1148725)
ORCID
22.58 7
38 Clinical impact of early post-transplant red cell transfusio… (10.3389/frtra.2023.1215130)
ORCID
22.58 7
39 The role of C4d and donor specific antibodies in face and ha… (10.3389/frtra.2024.1442006)
ORCID
22.58 7
40 Quality of life, anxiety, and depression improve at one-year… (10.3389/frtra.2024.1476952)
ORCID
22.58 7
41 Breaking the limits of experimental pancreas transplantation… (10.3389/frtra.2022.1035480)
ORCID
21.13 6
42 Temporal and spatial variability of immunosuppressive therap… (10.3389/frtra.2022.1060621)
ORCID
21.13 6
43 Mitochondrial responses to brain death in solid organ transp… (10.3389/frtra.2023.1082227)
ORCID
21.13 6
44 Type I interferons augment regulatory T cell polarization in… (10.3389/frtra.2023.1149334)
ORCID
21.13 6
45 Reduced immunomodulatory metabolite concentrations in peri-t… (10.3389/frtra.2023.1182534)
ORCID
21.13 6
46 Psychosocial assessment tools for use before transplantation… (10.3389/frtra.2023.1250184)
ORCID
21.13 6
47 Innate immune modulation in transplantation: mechanisms, cha… (10.3389/frtra.2023.1277669)
ORCID
21.13 6
48 BK polyomavirus infection: more than 50 years and still a th… (10.3389/frtra.2024.1309927)
ORCID
21.13 6
49 Long-term outcomes of lung transplantation with ex vivo lung… (10.3389/frtra.2024.1324851)
ORCID
21.13 6
50 invariant Natural Killer T cell therapy as a novel therapeut… (10.3389/frtra.2024.1353803)
ORCID
21.13 6